Aanjaneya Lifecare acquires Hyderabad based Apex Drugs and IntermediatesIllustrative image – not actual.

Mumbai based Aanjaneya Lifecare has acquired Hyderabad based Apex Drugs and Intermediates (ADIL).

The acquisition was valued at Rs 250 crore with debt of Rs 185 crore and equity dilution of Rs 65 crore. Aanjaneya has acquired ADIL’s assets, businesses, clients, licensees, employees and has merged both the companies’ operations. The acquisition will reduce its dependence on third parties for pricing and supply to a large extent. Also, it will help Aanjaneya Lifecare to widen its product portfolio in various therapeutic segments including AIDS, Diabetes and central nervous system.

← All latest storiesBack to top →